BR112014016710A8 - compostos, métodos de tratamento de uma condição inflamatória, de artrite reumatoide, de asma, de um distúrbio imunológico, composição farmacêutica, uso de um composto e invenção - Google Patents
compostos, métodos de tratamento de uma condição inflamatória, de artrite reumatoide, de asma, de um distúrbio imunológico, composição farmacêutica, uso de um composto e invençãoInfo
- Publication number
- BR112014016710A8 BR112014016710A8 BR112014016710A BR112014016710A BR112014016710A8 BR 112014016710 A8 BR112014016710 A8 BR 112014016710A8 BR 112014016710 A BR112014016710 A BR 112014016710A BR 112014016710 A BR112014016710 A BR 112014016710A BR 112014016710 A8 BR112014016710 A8 BR 112014016710A8
- Authority
- BR
- Brazil
- Prior art keywords
- asthma
- treating
- compounds
- compound
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261584863P | 2012-01-10 | 2012-01-10 | |
PCT/EP2013/050139 WO2013104575A1 (en) | 2012-01-10 | 2013-01-07 | Thienopyrimidine compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014016710A2 BR112014016710A2 (pt) | 2017-06-13 |
BR112014016710A8 true BR112014016710A8 (pt) | 2017-07-04 |
Family
ID=47553050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014016710A BR112014016710A8 (pt) | 2012-01-10 | 2013-01-07 | compostos, métodos de tratamento de uma condição inflamatória, de artrite reumatoide, de asma, de um distúrbio imunológico, composição farmacêutica, uso de um composto e invenção |
Country Status (11)
Country | Link |
---|---|
US (1) | US9701691B2 (pt) |
EP (1) | EP2802590B1 (pt) |
JP (1) | JP6109193B2 (pt) |
KR (1) | KR20140110066A (pt) |
CN (1) | CN104159904B (pt) |
BR (1) | BR112014016710A8 (pt) |
CA (1) | CA2860548A1 (pt) |
HK (1) | HK1203933A1 (pt) |
MX (1) | MX349548B (pt) |
RU (1) | RU2637925C2 (pt) |
WO (1) | WO2013104575A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6001048B2 (ja) * | 2011-03-28 | 2016-10-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | チアゾロピリミジン化合物 |
BR112016016098A2 (pt) * | 2014-01-09 | 2017-08-08 | Intracellular Therapies Inc | Compostos orgânicos |
CN111542529B (zh) * | 2017-11-30 | 2023-06-30 | 韩美药品株式会社 | 对蛋白激酶具有抑制活性的噻吩并[3,2-d]嘧啶化合物 |
US11292799B2 (en) * | 2017-12-15 | 2022-04-05 | UNION therapeutics A/S | Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors |
JP2022526713A (ja) | 2019-03-21 | 2022-05-26 | オンクセオ | がんの処置のための、キナーゼ阻害剤と組み合わせたDbait分子 |
CN110183464B (zh) * | 2019-05-31 | 2021-08-31 | 淮阴工学院 | 一种抗癌化合物艾斯替尼及其合成方法和应用 |
CN114761006A (zh) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | 对激酶抑制剂产生耐药性的癌症的治疗方法 |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
US20230250088A1 (en) * | 2020-07-15 | 2023-08-10 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK6652000A3 (en) | 1997-11-11 | 2002-05-09 | Pfizer Prod Inc | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
WO2002026745A1 (fr) * | 2000-09-29 | 2002-04-04 | Nippon Soda Co., Ltd. | Composes de thienopyrimidine et leurs sels et procede de preparation |
CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
US20080269238A1 (en) | 2004-04-01 | 2008-10-30 | Takeda Pharmaceutical Company Limited | Thiazolopyrimidine Derivative |
WO2008059368A2 (en) | 2006-11-17 | 2008-05-22 | Pfizer Products Inc. | Fused 2-amino pyrimidine compounds and their use for the treatment of cancer |
GB0718432D0 (en) | 2007-09-21 | 2007-10-31 | Vernalis R&D Ltd | New chemical compounds |
ATE537175T1 (de) * | 2007-10-19 | 2011-12-15 | Boehringer Ingelheim Int | Neue piperazino-dihydrothienopyrimidin-derivate |
EP2215094B1 (en) * | 2007-11-15 | 2016-01-27 | YM BioSciences Australia Pty Ltd | N-containing heterocyclic compounds |
WO2010023181A1 (en) * | 2008-08-26 | 2010-03-04 | Boehringer Ingelheim International Gmbh | Thienopyrimidines for pharmaceutical compositions |
KR101147550B1 (ko) * | 2009-10-22 | 2012-05-17 | 한국과학기술연구원 | 단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노[3,2-d]피리미딘 화합물 |
KR101094446B1 (ko) * | 2009-11-19 | 2011-12-15 | 한국과학기술연구원 | 단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물 |
KR101483215B1 (ko) * | 2010-01-29 | 2015-01-16 | 한미약품 주식회사 | 단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체 |
JP2013519044A (ja) * | 2010-02-08 | 2013-05-23 | ナショナル ウィンド エナジー カンパニー リミテッド | 垂直軸盤式発電機用磁気浮上支持構造とそれを用いた垂直軸盤式発電機 |
KR20190077610A (ko) * | 2010-07-13 | 2019-07-03 | 에프. 호프만-라 로슈 아게 | Irak4 조절제로서 피라졸로[1,5a]피리미딘 및 티에노[3,2b]피리미딘 유도체 |
-
2013
- 2013-01-07 CA CA2860548A patent/CA2860548A1/en not_active Abandoned
- 2013-01-07 RU RU2014131367A patent/RU2637925C2/ru not_active IP Right Cessation
- 2013-01-07 MX MX2014008155A patent/MX349548B/es active IP Right Grant
- 2013-01-07 BR BR112014016710A patent/BR112014016710A8/pt not_active Application Discontinuation
- 2013-01-07 WO PCT/EP2013/050139 patent/WO2013104575A1/en active Application Filing
- 2013-01-07 EP EP13700133.5A patent/EP2802590B1/en not_active Not-in-force
- 2013-01-07 JP JP2014550712A patent/JP6109193B2/ja not_active Expired - Fee Related
- 2013-01-07 CN CN201380013256.XA patent/CN104159904B/zh not_active Expired - Fee Related
- 2013-01-07 KR KR1020147022116A patent/KR20140110066A/ko not_active Application Discontinuation
- 2013-01-10 US US13/738,103 patent/US9701691B2/en not_active Expired - Fee Related
-
2015
- 2015-05-07 HK HK15104334.0A patent/HK1203933A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2637925C2 (ru) | 2017-12-08 |
US9701691B2 (en) | 2017-07-11 |
CN104159904A (zh) | 2014-11-19 |
JP2015503576A (ja) | 2015-02-02 |
CN104159904B (zh) | 2016-12-14 |
BR112014016710A2 (pt) | 2017-06-13 |
US20130178460A1 (en) | 2013-07-11 |
EP2802590A1 (en) | 2014-11-19 |
HK1203933A1 (en) | 2015-11-06 |
MX2014008155A (es) | 2014-10-14 |
EP2802590B1 (en) | 2017-03-01 |
JP6109193B2 (ja) | 2017-04-05 |
WO2013104575A1 (en) | 2013-07-18 |
RU2014131367A (ru) | 2016-02-27 |
KR20140110066A (ko) | 2014-09-16 |
MX349548B (es) | 2017-08-02 |
CA2860548A1 (en) | 2013-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014004569A2 (pt) | composto da fórmula i, métodos para tratar condição inflamatória, artrite reumatoide, asma e distúrbio imune, composição farmacêutica e uso do composto | |
BR112014016710A2 (pt) | compostos, métodos de tratamento de uma condição inflamatória, de artrite reumatoide, de asma, de um distúrbio imunológico, composição farmacêutica, uso de um composto e invenção | |
HK1249507A1 (zh) | 用於治療炎性障礙的新化合物及其藥物組合物 | |
ZA201802150B (en) | Compounds useful as modulators of trpm8 | |
CO6950482A2 (es) | Composiciones para el tratamiento de la artritis reumatoide y métodos para su utilización | |
DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
BR112016003229A2 (pt) | Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica | |
CO6930350A2 (es) | Mezclas de cemento-scm de partículas empacadas | |
ITUD20130141A1 (it) | Adsorbente di vaglio molecolare 5a e metodo per la preparazione dello stesso | |
DK2898061T3 (da) | Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande | |
BR112014023200A2 (pt) | uso de uma composição | |
BR112015024772A2 (pt) | composições para tratamento bucal contendo partículas de poli-organossilsesquioxano | |
DK2900767T3 (da) | Superhydrofobe pulverbelægninger | |
PL3106150T3 (pl) | Ulepszone kompozycje farmaceutyczne pimobendanu | |
BR112014013660A2 (pt) | uso de uma partícula | |
FR2987086B1 (fr) | Joint lineaire de plateforme inter-aubes | |
DK2897594T3 (da) | Farmaceutisk sammensætning | |
BR112015004427A2 (pt) | compostos , métodos para o tratamento de um estado inflamatório , da artrite reumatóide , da asma , de um distúrbio imunológico e de um distúrbio imune e composição farmacêutica | |
EP2906554A4 (en) | SOLID FORMS OF NILOTINIB HYDROCHLORIDE | |
EP2897630A4 (en) | ANTI-INFLAMMATORY COMPOSITIONS FOR THE TREATMENT OF NEUROGENIC INFLAMMATION | |
FI20125937A (fi) | Järjestely ja menetelmä rakenneosan kannattamiseksi | |
BR112014016736A8 (pt) | composto, composição farmacêutica, método para tratamento, uso de um composto e invenção | |
PL2991618T3 (pl) | Stabilna kompozycja farmaceutyczna o wysokim stężeniu lewoleukoworyny | |
CL2015000389A1 (es) | Aditivos para autorregeneracion de revestimientos epóxi | |
BR112014026397A2 (pt) | composição e uso de uma composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |